Latest

Learn how antibiotic-resistant UTI testing identifies ESBL, CRE, resistance genes, and antibiotic susceptibility, and how culture results guide treatment and follow-up.

Antibiotic-Resistant UTI Test: ESBL, CRE, Resistance Markers, and Culture Meaning

Learn what asymptomatic bacteriuria means, how a positive urine culture without UTI symptoms is interpreted, and when screening, treatment, or follow-up matters.

Asymptomatic Bacteriuria Test: Positive Culture Without Symptoms and When It Matters

Learn how bacteria in urine are interpreted using urinalysis, culture, colony count, symptoms, and sample quality, including when contamination or follow-up testing matters.

Bacteria in Urine Test: UTI, Contamination, Colony Count, and Culture Follow-Up

Learn how a catheter urine culture helps diagnose catheter-associated UTI, how samples are collected, and what colony counts, pyuria, resistance, and positive results mean.

Catheter Urine Culture Test: Catheter-Associated UTI and Culture Meaning

Learn how a chlamydia and gonorrhea urine NAAT works, how to collect first-catch urine, what positive or negative results mean, and when follow-up testing is needed.

Chlamydia and Gonorrhea Urine NAAT Test: STI Screening, Positive Result, and Meaning

Learn how to collect a clean-catch urine culture, reduce contamination, handle the sample correctly, and understand mixed flora, colony counts, repeat testing, and accurate results.

Clean-Catch Urine Culture Test: Sample Collection, Contamination, and Accurate Results

Diagnostics

Home Diagnostics Page 22

Learn how POLE mutation testing classifies endometrial cancer, which exonuclease-domain variants matter, and what POLE-mutated results mean for prognosis and treatment.

POLE Mutation Test for Endometrial Cancer: Molecular Subtype, Prognosis, and Mutation...

Learn what RAD51C and RAD51D ovarian cancer genetic tests mean, including hereditary risk, pathogenic variants, VUS results, preventive surgery, HRD biology, and family testing.

RAD51C and RAD51D Test for Ovarian Cancer: Hereditary Risk, DNA Repair,...

Learn how the ROMA ovarian cancer risk test combines CA-125, HE4, and menopause status, why cutoffs vary by assay, and what high or low risk scores mean before surgery.

ROMA Test for Ovarian Cancer Risk: CA-125, HE4, Menopause Status, and...

Learn how HPV, p16, and p53 classify vulvar squamous cell carcinoma, what block-positive and p53-abnormal patterns mean, and why tumor pathway affects prognosis and follow-up.

Vulvar Cancer Biomarker Panel: HPV, p16, p53, and Tumor Classification

Understand ALK fusion testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

ALK Fusion Test for Lung Cancer: Gene Fusion, Positive Result, and...

Understand BRAF V600E testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

BRAF V600E Test for Lung Cancer: Mutation Status, Positive Result, and...

Learn how the carcinoembryonic antigen (CEA) test is used in lung cancer, what high levels can mean, common non-cancer causes, reference ranges, and why serial trends matter.

CEA Test for Lung Cancer: Tumor Marker Monitoring, High Levels, and...

Learn how the cytokeratin 19 fragment 21-1 (CYFRA 21-1) test is used in lung cancer, what high levels can mean, common non-cancer causes, reference ranges, and why serial trends matter.

CYFRA 21-1 Test for Lung Cancer: Tumor Marker Levels and Disease...

Understand EGFR exon 20 insertion testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

EGFR Exon 20 Insertion Test: Lung Cancer Mutation Status and Molecular...

Understand EGFR mutation testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

EGFR Mutation Test for Lung Cancer: Exon 19, L858R, T790M, Mutation...

Understand EGFR T790M testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

EGFR T790M Test: Lung Cancer Resistance Mutation, ctDNA, and Result Meaning

Understand HER2/ERBB2 mutation testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

HER2/ERBB2 Mutation Test for Lung Cancer: Mutation Status and HER2 Alteration...

Understand KRAS G12C testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

KRAS G12C Test for Lung Cancer: Mutation Status, Positive Result, and...

Lung Cancer Biomarker Panel: EGFR, ALK, ROS1, BRAF, MET, RET, NTRK,...

Learn how lung cancer liquid biopsy uses ctDNA to detect actionable mutations and resistance markers, what positive and negative results mean, and when tissue testing is still needed.

Lung Cancer Liquid Biopsy Test: ctDNA, Mutations, Resistance Markers, and Blood-Based...

Lung Cancer NGS Panel Test: Driver Mutations, Gene Fusions, Resistance Markers,...

1...212223...137 Page 22 of 137